bf/NYSE:MRK_icon.jpeg

NYSE:MRK

Merck & Co., Inc. (MSD outside of the U.S. and Canada)

  • Stock

USD

Last Close

131.75

28/03 20:00

Market Cap

306.16B

Beta: 0.35

Volume Today

6.59M

Avg: 7.72M

PE Ratio

69.75

PFCF: 24.38

Dividend Yield

2.34%

Payout:159.35%

  • industry

    Drug Manufacturers / General
  • exchange

    New York Stock Exchange
  • website

    www.merck.com
  • ipo date

    Jun 15, 1946
  • full time employees

    67,000
  • currency

    USD

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, ...Show More

Earnings

Earnings per Share (Estimate*)

-2-1122015-04-282017-05-022019-04-302021-04-292023-04-27

Revenue (Estimate*)

5B10B15B2015-04-282017-05-022019-04-302021-04-292023-04-27

*Estimate based on analyst consensus

founders

  • George W. Merck

investors

PartnersFunding RoundInvestor NameLead Investor
Post-IPO Equity - MerckPrivate Capital AdvisorsYes
Venture Round - MerckGavi, the Vaccine AllianceYes

investments

Money RaisedFunding RoundLead InvestorAnnounced DateOrganization Name
$23.3MVenture Round - Prognos Health04-05-2023Prognos Health
$3.3MSeed Round - Mamotest27-03-2023Mamotest
$40MSeries C - Qure AI30-03-2022Qure AI
$1BPost-IPO Equity - SeagenYes14-09-2020Seagen
$3MSeries B - Zapata Computing28-08-2020Zapata Computing
$14MSeries B - SAB Biotherapeutics17-07-2020SAB Biotherapeutics
€40MSeries D - Themis Bioscience18-09-2019Themis Bioscience
Seed Round - Mesentech24-05-2019Mesentech
Series B - ClinithinkYes03-03-2019Clinithink
Non Equity Assistance - Kytopen04-02-2019Kytopen

acquisitions

PriceAcquiree NameAnnounced DateTransaction Name
Harpoon Therapeutics08-01-2024Harpoon Therapeutics acquired by Merck
$10.8BPrometheus Biosciences16-04-2023Prometheus Biosciences acquired by Merck
$1.4BImago BioSciences21-11-2022Imago BioSciences acquired by Merck
$11.5BAcceleron Pharma30-09-2021Acceleron Pharma acquired by Merck
$1.9BPandion Therapeutics25-02-2021Pandion Therapeutics acquired by Merck
$425MOncoImmune23-11-2020OncoImmune acquired by Merck
$2.8BVelosBio05-11-2020VelosBio acquired by Merck
Themis Bioscience26-05-2020Themis Bioscience acquired by Merck
$2.7BArQule09-12-2019ArQule acquired by Merck
$576MCalporta Therapeutics13-11-2019Calporta Therapeutics acquired by Merck

num employees

  • 10001+

funding rounds

Money RaisedAnnounced DateLead InvestorsTransaction NameNumber of Investors
$586K25-11-2018Private Capital AdvisorsPost-IPO Equity - Merck1
$5M21-01-2016Gavi, the Vaccine AllianceVenture Round - Merck1

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.